-+ 0.00%
-+ 0.00%
-+ 0.00%
Anika Therapeutics Raises FY2026 Sales Guidance from $118.460M-$124.101M to $119.588M-$124.101M vs $121.639M Est
Share
Listen to the news
Anika Therapeutics (NASDAQ:ANIK) raises FY2026 sales outlook from $118.460 million-$124.101 million to $119.588 million-$124.101 million vs $121.639 million estimate.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending